As discussed above, the BCL-2 family of proteins includes over a dozen members, each presenting different mode of regulation, post-translational modification, and protein–protein interactions, making difficult a correct prediction for BH3 mimetics’ response in cancer cells using standard molecular biology techniques. The gene discussed is BCL2; the disease is cancer.